Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000720819 | SCV000851703 | uncertain significance | Seizures | 2017-05-19 | criteria provided, single submitter | clinical testing | Insufficient evidence |
Invitae | RCV001056517 | SCV001220962 | uncertain significance | Familial focal epilepsy with variable foci | 2019-06-04 | criteria provided, single submitter | clinical testing | This sequence change replaces proline with alanine at codon 676 of the DEPDC5 protein (p.Pro676Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. This variant is present in population databases (rs199603004, ExAC 0.02%). This variant has not been reported in the literature in individuals with DEPDC5-related conditions. ClinVar contains an entry for this variant (Variation ID: 590145). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |